Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Stockholders' Equity

v3.25.1
Condensed Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock and Capital in Excess of Par Value, Shares
Common Stock and Capital in Excess of Par Value, Amount
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Jun. 30, 2023   136,750      
Beginning balance at Jun. 30, 2023 $ 2,919,753   $ 2,107,663 $ 848,431 $ (36,341)
Increase (Decrease) in Stockholders' Equity          
Net income 741,375     741,375  
Other comprehensive income (loss) (13,097)       (13,097)
Net issuance under employee stock plans (in shares)   173      
Net issuance under employee stock plans (68,237)   (68,237)    
Repurchase of common stock (in shares)   (956)      
Repurchase of common stock (459,093)   (14,722) (444,371)  
Cash dividends and dividend equivalents declared (179,256)     (179,256)  
Stock-based compensation expense 48,772   48,772    
Ending balance (in shares) at Sep. 30, 2023   135,967      
Ending balance at Sep. 30, 2023 2,990,217   2,073,476 966,179 (49,438)
Beginning balance (in shares) at Jun. 30, 2023   136,750      
Beginning balance at Jun. 30, 2023 2,919,753   2,107,663 848,431 (36,341)
Increase (Decrease) in Stockholders' Equity          
Net income 1,925,450        
Other comprehensive income (loss) $ (5,179)        
Repurchase of common stock (in shares) (2,392)        
Ending balance (in shares) at Mar. 31, 2024   134,713      
Ending balance at Mar. 31, 2024 $ 3,094,885   2,177,501 958,904 (41,520)
Beginning balance (in shares) at Sep. 30, 2023   135,967      
Beginning balance at Sep. 30, 2023 2,990,217   2,073,476 966,179 (49,438)
Increase (Decrease) in Stockholders' Equity          
Net income 582,534     582,534  
Other comprehensive income (loss) 17,174       17,174
Net issuance under employee stock plans (in shares)   141      
Net issuance under employee stock plans 45,427   45,427    
Repurchase of common stock (in shares)   (848)      
Repurchase of common stock (441,563)   (13,014) (428,549)  
Cash dividends and dividend equivalents declared (198,698)     (198,698)  
Stock-based compensation expense 48,620   48,620    
Ending balance (in shares) at Dec. 31, 2023   135,260      
Ending balance at Dec. 31, 2023 3,043,711   2,154,509 921,466 (32,264)
Increase (Decrease) in Stockholders' Equity          
Net income 601,541     601,541  
Other comprehensive income (loss) (9,256)       (9,256)
Net issuance under employee stock plans (in shares)   41      
Net issuance under employee stock plans $ (24,275)   (24,275)    
Repurchase of common stock (in shares) (588) (588)      
Repurchase of common stock $ (375,696)   (9,415) (366,281)  
Cash dividends and dividend equivalents declared (197,822)     (197,822)  
Stock-based compensation expense 56,682   56,682    
Ending balance (in shares) at Mar. 31, 2024   134,713      
Ending balance at Mar. 31, 2024 3,094,885   2,177,501 958,904 (41,520)
Beginning balance (in shares) at Jun. 30, 2024   134,425      
Beginning balance at Jun. 30, 2024 3,368,328   2,280,133 1,137,270 (49,075)
Increase (Decrease) in Stockholders' Equity          
Net income 945,851     945,851  
Other comprehensive income (loss) 23,571       23,571
Net issuance under employee stock plans (in shares)   134      
Net issuance under employee stock plans (72,245)   (72,245)    
Repurchase of common stock (in shares)   (740)      
Repurchase of common stock (570,936)   (12,536) (558,400)  
Cash dividends and dividend equivalents declared (196,555)     (196,555)  
Stock-based compensation expense 61,700   61,700    
Ending balance (in shares) at Sep. 30, 2024   133,819      
Ending balance at Sep. 30, 2024 3,559,714   2,257,052 1,328,166 (25,504)
Beginning balance (in shares) at Jun. 30, 2024   134,425      
Beginning balance at Jun. 30, 2024 3,368,328   2,280,133 1,137,270 (49,075)
Increase (Decrease) in Stockholders' Equity          
Net income 2,858,794        
Other comprehensive income (loss) $ 6,442        
Repurchase of common stock (in shares) (2,430)        
Repurchase of common stock $ (1,738,612)        
Ending balance (in shares) at Mar. 31, 2025   132,241      
Ending balance at Mar. 31, 2025 4,004,739   2,401,317 1,646,055 (42,633)
Beginning balance (in shares) at Sep. 30, 2024   133,819      
Beginning balance at Sep. 30, 2024 3,559,714   2,257,052 1,328,166 (25,504)
Increase (Decrease) in Stockholders' Equity          
Net income 824,527     824,527  
Other comprehensive income (loss) (20,882)       (20,882)
Net issuance under employee stock plans (in shares)   104      
Net issuance under employee stock plans 43,931   43,931    
Repurchase of common stock (in shares)   (979)      
Repurchase of common stock (655,973)   (16,478) (639,495)  
Cash dividends and dividend equivalents declared (228,609)     (228,609)  
Stock-based compensation expense 61,841   61,841    
Ending balance (in shares) at Dec. 31, 2024   132,944      
Ending balance at Dec. 31, 2024 3,584,549   2,346,346 1,284,589 (46,386)
Increase (Decrease) in Stockholders' Equity          
Net income 1,088,416     1,088,416  
Other comprehensive income (loss) 3,753       3,753
Net issuance under employee stock plans (in shares)   8      
Net issuance under employee stock plans $ (2,680)   (2,680)    
Repurchase of common stock (in shares) (711) (711)      
Repurchase of common stock $ (511,703)   (12,550) (499,153)  
Cash dividends and dividend equivalents declared (227,797)     (227,797)  
Stock-based compensation expense 70,201   70,201    
Ending balance (in shares) at Mar. 31, 2025   132,241      
Ending balance at Mar. 31, 2025 $ 4,004,739   $ 2,401,317 $ 1,646,055 $ (42,633)